Medistim ASA
F:MD1

Watchlist Manager
Medistim ASA Logo
Medistim ASA
F:MD1
Watchlist
Price: 18.8 EUR -1.83% Market Closed
Market Cap: €344.3m

Wall Street
Price Targets

MD1 Price Targets Summary
Medistim ASA

Wall Street analysts forecast MD1 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MD1 is 23.22 EUR with a low forecast of 17.69 EUR and a high forecast of 29.42 EUR.

Lowest
Price Target
17.69 EUR
6% Downside
Average
Price Target
23.22 EUR
24% Upside
Highest
Price Target
29.42 EUR
56% Upside
Medistim ASA Competitors:
Price Targets
9688
Zai Lab Ltd
119% Upside
PXS
Pyxis Tankers Inc
186% Upside
FDMT
4D Molecular Therapeutics Inc
303% Upside
ATC
Arctic Paper SA
39% Upside

Revenue
Forecast

10% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
10% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 13 years the compound annual growth rate for Medistim ASA's revenue is 10%. The projected CAGR for the next 3 years is 11%.

Operating Income
Forecast

14% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
14% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

For the last 13 years the compound annual growth rate for Medistim ASA's operating income is 14%. The projected CAGR for the next 3 years is 16%.

Net Income
Forecast

16% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
16% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

For the last 13 years the compound annual growth rate for Medistim ASA's net income is 16%. The projected CAGR for the next 3 years is 14%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MD1's stock price target?
Price Target
23.22 EUR

According to Wall Street analysts, the average 1-year price target for MD1 is 23.22 EUR with a low forecast of 17.69 EUR and a high forecast of 29.42 EUR.

What is Medistim ASA's Revenue forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Medistim ASA's revenue is 10%. The projected CAGR for the next 3 years is 11%.

What is Medistim ASA's Operating Income forecast?
Projected CAGR
16%

For the last 13 years the compound annual growth rate for Medistim ASA's operating income is 14%. The projected CAGR for the next 3 years is 16%.

What is Medistim ASA's Net Income forecast?
Projected CAGR
14%

For the last 13 years the compound annual growth rate for Medistim ASA's net income is 16%. The projected CAGR for the next 3 years is 14%.

Back to Top